TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line

Xiaohong Deng, Louise Fogh, Ulrik Axel Lademann, Vibeke Jensen, Jan Stenvang, Huanming Yang, Nils Brünner, Anne-Sofie Schrohl Rasmussen

    3 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'TIMP-1 overexpression does not affect sensitivity to HER2-targeting drugs in the HER2-gene-amplified SK-BR-3 human breast cancer cell line'. Together they form a unique fingerprint.

    Medicine & Life Sciences